In breast cancer cells, CD44 has been characterized as both a stem cell marker associated with metastasis and poor prognosis and as a tumor suppressor based on its interaction with hyaluronan, which can promote apoptosis through the activation of caspase 3 and the inhibition of PI3k activation and Akt phosphorylation [70]. The gene discussed is AKT1; the disease is breast cancer.